Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02134899Phase 3Completed
The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients
Autosomal Dominant Polycystic Kidney Disease
PrincipalinvestigatorStart date: 2014-10-14

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Assistance Publique - Hôpitaux de Paris

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Vimal Derebail, MD, MPH

University of North Carolina, Chapel Hill

Moderately Similar
2 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Kültigin Türkmen, Fellow

Istanbul University Istanbul Medical Faculty Department of Internal Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Thomas Fehr, MD

Cantonal Hospital Graubuenden

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Marva Moxey-Mims, M.D.

NIH, NIDDK, DKUH

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Tevfik Ecder, Professor

Istanbul University, Istanbul Medical Faculty, Department of Internal Medicine, Division of Nephrology

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Eiji Higashihara, MD

Kyorin University School of Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Eiji Higashihara, M.D.

Kyorin University

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Rian Dişçi, Professor

Istanbul University Istanbul Medical Faculty Department of Public Health

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Priya Velu, MD, PhD

Weill Medical College of Cornell University

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Patrick Hofmann, MD

Cantonal Hospital Graubuenden

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02134899Phase 3PrincipalInvestigator

The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients

Autosomal Dominant Polycystic Kidney Disease
Completed

All 1 trials loaded